Maximus vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: MEDVi scores higher on our rubric, 5.7/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.
MEDVi beats Maximus overall, scoring 5.7/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Maximus is published $79.99/mo; total not verified; MEDVi is $179 first month, then $299/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at Maximus and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Maximus
#50 of 54Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit MaximusMEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | Maximus | MEDVi |
|---|---|---|
| Why each one | Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market. | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. |
| Our Score | 5.1/10 | 5.7/10 |
| Headline Price | published $79.99/mo; total not verified | $179 first month, then $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 alongside testosterone or other men's health protocols | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #50 | #46 |
| Get started | Visit Maximus | Visit MEDVi |
Pros & Cons Compared
Maximus
Pros
- +Lowest published microdose medication price we track, $79.99/mo semaglutide; consultation and lab fees are separate
- +GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
- +Maximus markets a semaglutide formula with added glycine and B12 as a way to ease nausea; we found no Maximus-specific clinical trial validating that claim
- +Free expedited shipping on all medication orders
Cons
- −The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
- −Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
- −Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise
- −FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Maximus with a score of 5.7/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Maximus is published $79.99/mo; total not verified; MEDVi is $179 first month, then $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Maximus and MEDVi.
- Maximus vs Willowfrom $299/mo
- Maximus vs MyStart Healthfrom $299/mo
- Maximus vs Mochi Healthfrom $178/mo
- MEDVi vs GobyMedsfrom $99/mo
- MEDVi vs Lemonaid Healthpublished $129/mo; total not verified
- MEDVi vs WeightWatchers (Sequence)$74/mo membership + medication
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: MEDVi · 5.7/10